(CRAI) CRA International - Overview
Sector: Industrials | Industry: Consulting Services | Exchange: NASDAQ (USA) | Market Cap: 958m USD | Total Return: -20% in 12m
Avg Turnover: 21.8M
EPS Trend: 93.4%
Qual. Beats: 0
Rev. Trend: 99.7%
Qual. Beats: 4
Warnings
No concerns identified
Tailwinds
Confidence, Garp
CRA International (CRAI) is a global consulting firm specializing in economic, financial, and management advisory services. The company provides data-driven research, expert testimony for litigation, and strategic guidance for regulatory proceedings across diverse sectors, including life sciences, energy, and financial services.
Operating within the specialized consulting industry, the business model relies heavily on the recruitment and retention of high-level subject matter experts and PhD-level economists. This professional services model typically benefits from counter-cyclical demand, as litigation and restructuring activity often increase during periods of economic volatility.
For a detailed analysis of the companys historical performance and valuation metrics, consider exploring the data available on ValueRay.
Headquartered in Boston and established in 1965, the firm supports corporate clients and legal counsel through forensic accounting, intellectual property valuation, and market demand estimation. Its broad industry reach allows it to mitigate exposure to downturns in any single market segment.
- Rising demand for litigation and regulatory consulting services increases billable hours
- Legal and regulatory complexity drives higher utilization rates for expert testimony
- Expansion of life sciences and energy practices diversifies global revenue streams
- Consultant recruitment and retention costs impact overall operating profit margins
- Global economic uncertainty affects corporate spending on management and strategic consulting
| Net Income: 47.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA -5.27 > 1.0 |
| NWC/Revenue: -8.35% < 20% (prev 1.09%; Δ -9.44% < -1%) |
| CFO/TA -0.02 > 3% & CFO -11.5m > Net Income 47.9m |
| Net Debt (335.8m) to EBITDA (100.5m): 3.34 < 3 |
| Current Ratio: 0.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (6.59m) vs 12m ago -3.99% < -2% |
| Gross Margin: 27.15% > 18% (prev 0.31%; Δ 2.68k% > 0.5%) |
| Asset Turnover: 123.0% > 50% (prev 118.1%; Δ 4.90% > 0%) |
| Interest Coverage Ratio: 19.11 > 6 (EBITDA TTM 100.5m / Interest Expense TTM 3.92m) |
| A: -0.10 (Total Current Assets 316.5m - Total Current Liabilities 380.8m) / Total Assets 662.4m |
| B: 0.32 (Retained Earnings 209.2m / Total Assets 662.4m) |
| C: 0.12 (EBIT TTM 74.9m / Avg Total Assets 626.4m) |
| D: 0.43 (Book Value of Equity 198.4m / Total Liabilities 464.0m) |
| Altman-Z'' = 1.64 = BB |
| DSRI: 0.90 (Receivables 233.3m/234.8m, Revenue 770.7m/697.5m) |
| GMI: 1.13 (GM 27.15% / 30.58%) |
| AQI: 1.11 (AQ_t 0.36 / AQ_t-1 0.32) |
| SGI: 1.10 (Revenue 770.7m / 697.5m) |
| TATA: 0.09 (NI 47.9m - CFO -11.5m) / TA 662.4m) |
| Beneish M = -2.76 (Cap -4..+1) = A |
As of May 29, 2026, the stock is trading at USD 148.35 with a total of 140,856 shares traded.
Over the past week, the price has changed by +0.62%,
over one month by -3.76%,
over three months by -13.46% and
over the past year by -19.96%.
CRA International has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold CRAI.
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 252.5 | 70.2% |
P/E Trailing = 20.5589
P/E Forward = 17.4216
P/S = 1.243
P/B = 4.8309
P/EG = 1.0884
Revenue TTM = 770.7m USD
EBIT TTM = 74.9m USD
EBITDA TTM = 100.5m USD
Long Term Debt = 70.9m USD (estimated: total debt 280.1m - short term 209.2m)
Short Term Debt = 209.2m USD (from shortTermDebt, last quarter)
Debt = 368.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 88.1m
Net Debt = 335.8m USD (calculated: Debt 368.3m - CCE 32.5m)
Enterprise Value = 1.29b USD (958.0m + Debt 368.3m - CCE 32.5m)
Interest Coverage Ratio = 19.11 (Ebit TTM 74.9m / Interest Expense TTM 3.92m)
EV/FCF = -76.04x (Enterprise Value 1.29b / FCF TTM -17.0m)
FCF Yield = -1.32% (FCF TTM -17.0m / Enterprise Value 1.29b)
FCF Margin = -2.21% (FCF TTM -17.0m / Revenue TTM 770.7m)
Net Margin = 6.22% (Net Income TTM 47.9m / Revenue TTM 770.7m)
Gross Margin = 27.15% ((Revenue TTM 770.7m - Cost of Revenue TTM 561.5m) / Revenue TTM)
Gross Margin QoQ = 26.15% (prev 24.06%)
Tobins Q-Ratio = 1.95 (Enterprise Value 1.29b / Total Assets 662.4m)
Interest Expense / Debt = 1.06% (Interest Expense 3.92m / Debt 368.3m)
Taxrate = 36.02% (6.27m / 17.4m)
NOPAT = 47.9m (EBIT 74.9m * (1 - 36.02%))
Current Ratio = 0.83 (Total Current Assets 316.5m / Total Current Liabilities 380.8m)
Debt / Equity = 1.86 (Debt 368.3m / totalStockholderEquity, last quarter 198.4m)
Debt / EBITDA = 3.34 (Net Debt 335.8m / EBITDA 100.5m)
Debt / FCF = -19.73 (negative FCF - burning cash) (Net Debt 335.8m / FCF TTM -17.0m)
Total Stockholder Equity = 202.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.65% (Net Income 47.9m / Total Assets 662.4m)
RoE = 23.64% (Net Income TTM 47.9m / Total Stockholder Equity 202.7m)
RoCE = 27.38% (EBIT 74.9m / Capital Employed (Equity 202.7m + L.T.Debt 70.9m))
RoIC = 10.45% (NOPAT 47.9m / Invested Capital 458.3m)
WACC = 5.50% (E(958.0m)/V(1.33b) * Re(7.35%) + D(368.3m)/V(1.33b) * Rd(1.06%) * (1-Tc(0.36)))
Discount Rate = 7.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.67 | Cagr: -3.01%
[DCF] Fair Price = unknown (Cash Flow -17.0m)
EPS Correlation: 93.41 | EPS CAGR: 20.16% | SUE: -0.16 | # QB: 0
Revenue Correlation: 99.67 | Revenue CAGR: 9.32% | SUE: 2.13 | # QB: 4
EPS current Quarter (2026-06-30): EPS=2.15 | Chg30d=+3.37% | Revisions=+33% | Analysts=3
EPS next Quarter (2026-09-30): EPS=2.19 | Chg30d=+2.65% | Revisions=+33% | Analysts=3
EPS current Year (2026-12-31): EPS=8.60 | Chg30d=+0.74% | Revisions=+14% | GrowthEPS=+4.5% | GrowthRev=+6.6%
EPS next Year (2027-12-31): EPS=9.63 | Chg30d=+1.44% | Revisions=+33% | GrowthEPS=+12.1% | GrowthRev=+4.6%
[Analyst] Revisions Ratio: +33%